Novo Nordisk's oral semaglutide gets EU approval for heart related treatment of type 2 diabet
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Prior to this appointment, he served as Vice-Chancellor of Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur,
Shantived Hospital generated revenue of around Rs 50 crore in FY2025
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
Breakthrough UNITY 4D Phaco delivers up to 2X faster nucleus removal and 41% less energy into the eye
It will focus on interface between API and formulation manufacturing, reducing carbon footprint in formulation production, creating intellectual property, training next-generation scientists, and setting new industry benchmarks
This is Lupin's first product using proprietary Nanomi's technology and has a 180-day CGT exclusivity
This authorization follows FDA approval in June and WHO’s July recommendation adding twice-yearly lenacapavir as a PrEP option
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
The complex four-hour surgery was performed by a multidisciplinary team of doctors
Subscribe To Our Newsletter & Stay Updated